Natural killer cell stimulatory factor or interleukin 12 (NKSF/IL-12) is a heterodimeric cytokine produced by monocytes/macrophages, B cells, and possibly other accessory cell types primarily in response to bacteria or bacterial products. NKSF/IL-12 mediates pleiomorphic biological activity on T and NK cells and, alone or in synergy with other inducers, is a powerful stimulator of interferon gamma (IFN-gamma) production. IL-10 is a potent inhibitor of monocyte-macrophage activation, that inhibits production of tumor necrosis factor alpha (TNF-alpha), IL-1 and also IFN-gamma from lymphocytes acting at the level of accessory cells. Because TNF-alpha and IL-1 are not efficient inducers of IFN-gamma, the mechanism by which IL-10 inhibits IFN-gamma production is not clear. In this paper, we show that IL-10 is a potent inhibitor of NKSF/IL-12 production from human peripheral blood mononuclear cells activated with Staphylococcus aureus or lipopolysaccharide (LPS). Both the production of the free NKSF/IL-12 p40 chain and the biologically active p70 heterodimer are blocked by IL-10. NKSF/IL-12 p40 chain mRNA accumulation is strongly induced by S. aureus or LPS and downregulated by IL-10, whereas the p35 mRNA is constitutively expressed and only minimally regulated by S. aureus, LPS, or IL-10. Although IL-10 is able to block the production of NKSF/IL-12, a powerful inducer of IFN-gamma both in vitro and in vivo, the mechanism of inhibition of IFN-gamma by IL-10 cannot be explained only on the basis of inhibition of NKSF/IL-12 because IL-10 can partially inhibit IFN-gamma production induced by NKSF/IL-12, and also, the IFN-gamma production in response to various stimuli in the presence of neutralizing antibodies to NKSF/IL-12. Our findings that antibodies against NKSF/IL-12, TNF-alpha, or IL-1 beta can significantly inhibit IFN-gamma production in response to various stimuli and that NKSF/IL-12 and IL-1 beta can overcome the IL-10-mediated inhibition of IFN-gamma, suggest that IL-10 inhibition of IFN-gamma production is primarily due to its blocking production from accessory cells of the IFN-gamma-inducer NKSF/IL-12, as well as the costimulating molecule IL-1 beta.
Skip Nav Destination
Article navigation
1 September 1993
Article|
September 01 1993
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
A D'Andrea,
A D'Andrea
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Search for other works by this author on:
M Aste-Amezaga,
M Aste-Amezaga
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Search for other works by this author on:
N M Valiante,
N M Valiante
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Search for other works by this author on:
X Ma,
X Ma
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Search for other works by this author on:
M Kubin,
M Kubin
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Search for other works by this author on:
G Trinchieri
G Trinchieri
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Search for other works by this author on:
A D'Andrea
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
M Aste-Amezaga
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
N M Valiante
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
X Ma
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
M Kubin
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
G Trinchieri
The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1993) 178 (3): 1041–1048.
Citation
A D'Andrea, M Aste-Amezaga, N M Valiante, X Ma, M Kubin, G Trinchieri; Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.. J Exp Med 1 September 1993; 178 (3): 1041–1048. doi: https://doi.org/10.1084/jem.178.3.1041
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement